Head and neck cancer: Buparlisib is an effective second-line treatment.
Nat Rev Clin Oncol. 2017 Feb 14;:
Authors: Sidaway P
PMID: 28195237 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου